Headquarters
116 RESEARCH DR, BETHLEHEM, PA 18015-4731, US
BETHLEHEM, PA, US
AZEVAN PHARMACEUTICALS INC.
From the company
Azevan Pharmaceuticals is a clinical-stage biopharmaceutical company developing first-in-class, orally bioavailable vasopressin V1a receptor antagonists for neuropsychiatric disorders, neurodegeneration, neurodevelopment, and brain injury. Its lead candidate SRX246 has shown Phase 2 efficacy in pathological aggression in Huntington's disease and Intermittent Explosive Disorder. The company has four clinical and preclinical programs and has raised $56M in funding.
Products & services offered
Capabilities 2
Facilities
Send your requirements
Quantities, certifications, and timing.